FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890507526> ?p ?o ?g. }

• W2890507526 abstract "The use of molecularly targeted therapy is becoming widespread in oncology. These agents cause tumour-specific genetic alterations in signal transduction pathways, hence less generalised toxicity. Dabrafenib, a BRAF inhibitor and Trametinib, a MEK inhibitor are two molecularly targeted agents recently approved for treatment of advanced, unresectable melanomas. MEK retinopathy is a recently introduced term describing retinal toxicity secondary to MEK inhibitors. A 71-year-old man presented with ‘circular, green patches’ in his central vision for 2 weeks. He had multiple relapsed stage IV BRAF gene mutant malignant melanoma. He was on treatment with Dabrafenib (Tafinlar) for 7 months and Trametinib (Mekinist) for 4 months respectively. The fundus looked normal. The OCT scan showed bilateral symmetrical cystoid macular edema, intraretinal and subretinal fluid, thickening of elliposoid zone and subretinal granular deposits. The symptoms resolved with temporary cessation of chemotherapy but OCT signs persisted. This case report identifies two new remarkable features of MEK retinopathy as thickening of ellipsoid zone and ‘starry sky’ pattern of distribution of subretinal granular deposits. These changes signify photoreceptors/ RPE toxicity and dysfunction. The subretinal granular deposits showed increased autofluorescence suggested abnormal lipofuscin clearance due to RPE dysfunction. The molecularly targeted therapy has revolutionized the cancer treatment and increased the survival rate. These agents are relatively new and recently approved for clinical use and most of them are associated with ocular toxicities. Awareness of ocular symptoms, side-effect profile of drugs, monitoring regime and liaison between oncologist and eye care professional with ocular imaging is key to early diagnosis and management of ocular adverse events." @default.
• W2890507526 created "2018-09-27" @default.
• W2890507526 creator A5019397071 @default.
• W2890507526 creator A5040441063 @default.
• W2890507526 date "2018-09-01" @default.
• W2890507526 modified "2023-10-16" @default.
• W2890507526 title "New features in MEK retinopathy" @default.
• W2890507526 cites W1984810353 @default.
• W2890507526 cites W2011582933 @default.
• W2890507526 cites W2019441047 @default.
• W2890507526 cites W2054319863 @default.
• W2890507526 cites W2090628379 @default.
• W2890507526 cites W2102342979 @default.
• W2890507526 cites W2105704253 @default.
• W2890507526 cites W2115562945 @default.
• W2890507526 cites W2135925159 @default.
• W2890507526 cites W2140494950 @default.
• W2890507526 cites W2155111125 @default.
• W2890507526 cites W2156078931 @default.
• W2890507526 cites W2294989188 @default.
• W2890507526 cites W2426702004 @default.
• W2890507526 cites W2509999533 @default.
• W2890507526 cites W584714177 @default.
• W2890507526 doi "https://doi.org/10.1186/s12886-018-0861-8" @default.
• W2890507526 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6157024" @default.
• W2890507526 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30255823" @default.
• W2890507526 hasPublicationYear "2018" @default.
• W2890507526 type Work @default.
• W2890507526 sameAs 2890507526 @default.
• W2890507526 citedByCount "24" @default.
• W2890507526 countsByYear W28905075262018 @default.
• W2890507526 countsByYear W28905075262019 @default.
• W2890507526 countsByYear W28905075262020 @default.
• W2890507526 countsByYear W28905075262021 @default.
• W2890507526 countsByYear W28905075262022 @default.
• W2890507526 countsByYear W28905075262023 @default.
• W2890507526 crossrefType "journal-article" @default.
• W2890507526 hasAuthorship W2890507526A5019397071 @default.
• W2890507526 hasAuthorship W2890507526A5040441063 @default.
• W2890507526 hasBestOaLocation W28905075261 @default.
• W2890507526 hasConcept C118487528 @default.
• W2890507526 hasConcept C121608353 @default.
• W2890507526 hasConcept C126322002 @default.
• W2890507526 hasConcept C134018914 @default.
• W2890507526 hasConcept C143998085 @default.
• W2890507526 hasConcept C185592680 @default.
• W2890507526 hasConcept C2776131300 @default.
• W2890507526 hasConcept C2777658100 @default.
• W2890507526 hasConcept C2778313320 @default.
• W2890507526 hasConcept C2778472372 @default.
• W2890507526 hasConcept C2778830669 @default.
• W2890507526 hasConcept C2780347916 @default.
• W2890507526 hasConcept C2780827179 @default.
• W2890507526 hasConcept C2781230642 @default.
• W2890507526 hasConcept C2781249067 @default.
• W2890507526 hasConcept C2994587330 @default.
• W2890507526 hasConcept C502942594 @default.
• W2890507526 hasConcept C55493867 @default.
• W2890507526 hasConcept C555293320 @default.
• W2890507526 hasConcept C57074206 @default.
• W2890507526 hasConcept C62478195 @default.
• W2890507526 hasConcept C71924100 @default.
• W2890507526 hasConceptScore W2890507526C118487528 @default.
• W2890507526 hasConceptScore W2890507526C121608353 @default.
• W2890507526 hasConceptScore W2890507526C126322002 @default.
• W2890507526 hasConceptScore W2890507526C134018914 @default.
• W2890507526 hasConceptScore W2890507526C143998085 @default.
• W2890507526 hasConceptScore W2890507526C185592680 @default.
• W2890507526 hasConceptScore W2890507526C2776131300 @default.
• W2890507526 hasConceptScore W2890507526C2777658100 @default.
• W2890507526 hasConceptScore W2890507526C2778313320 @default.
• W2890507526 hasConceptScore W2890507526C2778472372 @default.
• W2890507526 hasConceptScore W2890507526C2778830669 @default.
• W2890507526 hasConceptScore W2890507526C2780347916 @default.
• W2890507526 hasConceptScore W2890507526C2780827179 @default.
• W2890507526 hasConceptScore W2890507526C2781230642 @default.
• W2890507526 hasConceptScore W2890507526C2781249067 @default.
• W2890507526 hasConceptScore W2890507526C2994587330 @default.
• W2890507526 hasConceptScore W2890507526C502942594 @default.
• W2890507526 hasConceptScore W2890507526C55493867 @default.
• W2890507526 hasConceptScore W2890507526C555293320 @default.
• W2890507526 hasConceptScore W2890507526C57074206 @default.
• W2890507526 hasConceptScore W2890507526C62478195 @default.
• W2890507526 hasConceptScore W2890507526C71924100 @default.
• W2890507526 hasIssue "S1" @default.
• W2890507526 hasLocation W28905075261 @default.
• W2890507526 hasLocation W28905075262 @default.
• W2890507526 hasLocation W28905075263 @default.
• W2890507526 hasLocation W28905075264 @default.
• W2890507526 hasLocation W28905075265 @default.
• W2890507526 hasOpenAccess W2890507526 @default.
• W2890507526 hasPrimaryLocation W28905075261 @default.
• W2890507526 hasRelatedWork W1453870474 @default.
• W2890507526 hasRelatedWork W1640208874 @default.
• W2890507526 hasRelatedWork W1974889077 @default.
• W2890507526 hasRelatedWork W2017844495 @default.
• W2890507526 hasRelatedWork W2028684492 @default.
• W2890507526 hasRelatedWork W2125845533 @default.
• W2890507526 hasRelatedWork W2566925333 @default.
• W2890507526 hasRelatedWork W3106550718 @default.

• next